316 related articles for article (PubMed ID: 12777270)
1. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.
Richardson MA; Bevans ML; Read LL; Chao HM; Clelland JD; Suckow RF; Maher TJ; Citrome L
Am J Psychiatry; 2003 Jun; 160(6):1117-24. PubMed ID: 12777270
[TBL] [Abstract][Full Text] [Related]
2. Treatment of tardive dyskinesia with vitamin E.
Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
[TBL] [Abstract][Full Text] [Related]
3. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
4. Branched chain amino acids decrease tardive dyskinesia symptoms.
Richardson MA; Bevans ML; Weber JB; Gonzalez JJ; Flynn CJ; Amira L; Read LL; Suckow RF; Maher TJ
Psychopharmacology (Berl); 1999 Apr; 143(4):358-64. PubMed ID: 10367552
[TBL] [Abstract][Full Text] [Related]
5. Factors in the development of severe forms of tardive dyskinesia.
Yassa R; Nair NP; Iskander H; Schwartz G
Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
7. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
[TBL] [Abstract][Full Text] [Related]
8. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.
Jeste DV; Lacro JP; Palmer B; Rockwell E; Harris MJ; Caligiuri MP
Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570
[TBL] [Abstract][Full Text] [Related]
9. Tardive dyskinesia and glucid metabolism.
Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
[TBL] [Abstract][Full Text] [Related]
10. Comparison of severe and mild tardive dyskinesia: implications for etiology.
Gardos G; Cole JO; Schniebolk S; Salomon M
J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
[TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia and impaired glucose tolerance.
Chong SA; Mythily ; Lum A; Huak CY; Kane J
Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone.
Jeste DV; Okamoto A; Napolitano J; Kane JM; Martinez RA
Am J Psychiatry; 2000 Jul; 157(7):1150-5. PubMed ID: 10873925
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.
Ganzini L; Heintz RT; Hoffman WF; Casey DE
Arch Gen Psychiatry; 1991 Mar; 48(3):259-63. PubMed ID: 1671743
[TBL] [Abstract][Full Text] [Related]
14. Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
Caroff SN; Walker P; Campbell C; Lorry A; Petro C; Lynch K; Gallop R
J Clin Psychiatry; 2007 Mar; 68(3):410-5. PubMed ID: 17388711
[TBL] [Abstract][Full Text] [Related]
15. Is melatonin treatment effective for tardive dyskinesia?
Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Lohr JB; Caligiuri MP
J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
[TBL] [Abstract][Full Text] [Related]
17. Serum prolactin and tardive dyskinesia.
Glazer WM; Moore DC; Bowers MD; Brown WA
Am J Psychiatry; 1981 Nov; 138(11):1493-6. PubMed ID: 6117204
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.
Adler LA; Rotrosen J; Edson R; Lavori P; Lohr J; Hitzemann R; Raisch D; Caligiuri M; Tracy K
Arch Gen Psychiatry; 1999 Sep; 56(9):836-41. PubMed ID: 12892048
[TBL] [Abstract][Full Text] [Related]
19. Prevention and management of tardive dyskinesia.
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
[TBL] [Abstract][Full Text] [Related]
20. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
